Reply to the Letter to the Editor Entitled “NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?”
Restricted accessReplyFirst published online January, 2020
Reply to the Letter to the Editor Entitled “NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?”
TuranY. The nonalcoholic fatty liver disease fibrosis score is related to epicardial fat thickness and complexity of coronary artery disease. Angiology. 2019. doi:10.1177/0003319719844933.
2.
YilmazYErenF. NFS is not a marker of nonalcoholic fatty liver disease per se: what is the true relationship with cad complexity?Angiology. 2019. doi:10.1177/0003319719862458.
3.
AnguloPHuiJMMarchesiniG, et al.The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846–54.
4.
EASL-EASD-EASO. Clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–402.
5.
RinellaME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263–73.
6.
SimonTGCoreyKECannonCP, et al.The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe. Int J Cardiol. 2018;270:245–52.
7.
SinghALePPeerzadaMMLopezRAlkhouriN. The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 2 diabetic patients. J Clin Gastroenterol. 2018;52(3):268–72.
8.
SinghALePLopezRAlkhouriN. The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients. Hepatol Int. 2018;12(1):37–43.
9.
TakahashiYKurosakiMTamakiN, et al.Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications. Hepatol Res. 2015;45(6):667–75.
10.
Unalp-AridaARuhlCE. Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology. 2017;66(1):84–95.
11.
YilmazYKurtRGurdalA, et al.Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis. 2011;217(1):125–29.
12.
SunbulMAgirbasliMDurmusE, et al.Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. Atherosclerosis. 2014;237(2):490–3.
